Advantage Medication records with a DEA Class Code assigned are not included in the Denominator calculation for Meaningful Use Core Set 4.Due to DEA and Subscripts requirements, scheduled drugs (under the Controlled Substances Act) may not be transmitted through the NewCrop interface. They must be printed out, manually signed and manually faxed to the pharmacy.
Schedule II drugs, such as Percodan, have always required a print and manual signature (often called a 'wet' signature). Although the ability to transmit Schedule III, IV and V drugs has varied by state, Surescripts has mandated that all scheduled drugs are handled in the same way. All scheduled drugs must be printed out, manually signed and faxed at this time.
Advantage Medication records with a DEA Class Code assigned are not included in the Denominator calculation for Meaningful Use Core Set 4.
Schedule II Drugs:
The drug or other substance has a high potential for abuse.
The drug or other substance has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions.
Abuse of the drug or other substances may lead to severe psychological or physical dependence.
Schedule III Drugs:
The drug or other substance has a potential for abuse less than the drugs or other substances in schedules I and II.
The drug or other substance has a currently accepted medical use in treatment in the United States.
Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence.
Schedule IV Drugs:
The drug or other substance has a low potential for abuse relative to the drugs or other substances in schedule III.
The drug or other substance has a currently accepted medical use in treatment in the United States.
Abuse of the drug or other substance may lead to limited physical dependence or psychological dependence relative to the drugs or other substances in schedule III.
Schedule V Drugs:
The drug or other substance has a low potential for abuse relative to the drugs or other substances in schedule IV.
The drug or other substance has a currently accepted medical use in treatment in the United States.
Abuse of the drug or other substance may lead to limited physical dependence or psychological dependence relative to the drugs or other substances in schedule IV.